Monoclonal Anti-DM-4 Antibody, Rabbit IgG (M1A02), Unconjugated, Human

Produktübersicht

• Artikelname: Monoclonal Anti-DM-4 Antibody, Rabbit IgG (M1A02), Unconjugated, Human
• Artikelnummer: ABS-DM4-MY2517-1MG
• Hersteller Artikelnummer: DM4-MY2517-1mg
• Alternativnummer: ABS-DM4-MY2517-1MG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Rabbit
• Konjugation: Unconjugated

Produktbeschreibung

DM4 (also known as ravtansine or soravtansine) is a maytansinoid derivative that serves as a potent cytotoxic payload in antibodydrug conjugates (ADCs). It functions by inhibiting tubulin polymerization, arresting cell division, and inducing apoptosis in tumor cells. Structurally modified from DM1, DM4 enhances conjugation compatibility with linkers and has been used in several clinical ADC drugs, including mirvetuximab soravtansine for ovarian cancer treatment. - Antikörper

Produkteigenschaften

• Tag: Rabbit IgG | Rabbit Kappa
• Puffer: PBS, pH7.4
• Formulierung: Powder
• Target-Kategorie: DM-4

Bilder

Immobilized Monoclonal Anti-DM-4 Antibody, Rabbit IgG (M1A02) (Cat. No. DM4-MY2517a) at 1 µg/mL, add Tusamitamab Ravtansine in the 100% Human Serum and then add Biotinylated Human CEACAM-5, His,Avitag at 0.5 µg/mL. Detection was performed using HRP-conjugated Streptavidin (Acro, Cat. No. STN-NH913) (QC tested).

Serial dilutions of DM4 were added into Monoclonal Anti-DM-4 Antibody, Rabbit IgG (M1A02) (Cat. No. DM4-MY2517): Tusamitamab Ravtansine binding reactions. The half maximal inhibitory concentration (IC50) is 0.60 µg/mL (Routinely tested).